Nuclearelectrica and Romgaz will replace pharmaceuticals company Biofarm (BIO.RO) and lender Banca Carpatica (BCC.RO) in the index as of December 23.
“Romgaz and Nuclearelectrica were included in the stock exchange’s main index based on the shares’ liquidity in the market. This in turn will support the future liquidity of these assets, enhancing their valuation through the price discovery mechanism,” said Ludwik Sobolewski, chief executive of the Bucharest StocK Exchange.
Moreover, the shares of Nuclearelectrica and Romgaz will be included in the bourse’s wider indices BET-XT and BET-BK, as well as in the BET-C and the energy tracker BET-NG.
The BET-XT tracks the shares of the top 25 best-performing Romanian companies traded in Bucharest, including the five regional investment funds SIFs and Fondul Proprietatea (FP.RO). The BET-BK includes the 25 best-performing issuers, be they Romanian or foreign.
Nuclearelectrica and Romgaz were listed on the Bucharest Stock Exchange on November 4 and November 12, respectively.
At around 11:50 am, Nuclearelectrica’s shares traded down 0.26% at RON11.34, while Romgaz was down 0.85% at RON35.1, amid a declining market.